Last Updated : June 8, 2004
Details
FilesGeneric Name:
Teriparatide (rDNA origin) injection
Project Status:
Complete
Therapeutic Area:
Osteoporosis
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Forteo
Project Line:
Reimbursement Review
Project Number:
SR0015-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Osteoporosis
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.
Files
Last Updated : June 8, 2004